Why are patients with malignant lymphomas excluded from clinical trials? The experience of an Oncology Institute in Italy [1]

D. Serraino, V. Zagonel, R. Bordonaro, S. Franceschi

Research output: Contribution to journalArticle

1 Citation (Scopus)
Original languageEnglish
Pages (from-to)427-428
Number of pages2
JournalEuropean Journal of Cancer
Volume34
Issue number3
Publication statusPublished - Feb 1998

ASJC Scopus subject areas

  • Cancer Research
  • Hematology
  • Oncology

Cite this

Why are patients with malignant lymphomas excluded from clinical trials? The experience of an Oncology Institute in Italy [1]. / Serraino, D.; Zagonel, V.; Bordonaro, R.; Franceschi, S.

In: European Journal of Cancer, Vol. 34, No. 3, 02.1998, p. 427-428.

Research output: Contribution to journalArticle

@article{7c5cdeabab3e48a48b99bf4aeb425bd8,
title = "Why are patients with malignant lymphomas excluded from clinical trials? The experience of an Oncology Institute in Italy [1]",
author = "D. Serraino and V. Zagonel and R. Bordonaro and S. Franceschi",
year = "1998",
month = "2",
language = "English",
volume = "34",
pages = "427--428",
journal = "European Journal of Cancer",
issn = "0959-8049",
publisher = "Elsevier Ltd",
number = "3",

}

TY - JOUR

T1 - Why are patients with malignant lymphomas excluded from clinical trials? The experience of an Oncology Institute in Italy [1]

AU - Serraino, D.

AU - Zagonel, V.

AU - Bordonaro, R.

AU - Franceschi, S.

PY - 1998/2

Y1 - 1998/2

UR - http://www.scopus.com/inward/record.url?scp=17344390590&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=17344390590&partnerID=8YFLogxK

M3 - Article

VL - 34

SP - 427

EP - 428

JO - European Journal of Cancer

JF - European Journal of Cancer

SN - 0959-8049

IS - 3

ER -